Heart Failure Heart Failure
Conditions
Interventions
Mesurement of the sweat lactate with the clinical trial device attached to the forehead in a incrematnal exercise test
Sponsors
Katsumata Yoshinori
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Patients who can voluntarily obtain consent to participate in the clinical trial in writing from the patient. (2) Men and women aged between 20 and 90 at the time of consent and suffering from New York Heart Association functional classification (NYHA) I or II heart failure. (3) Patients planning to receive exercise therapy.
Exclusion criteria
Exclusion criteria: (1) Patients with severe skin diseases. (2) Patients with lacerations at the device application site. (3) Patients with extremely low sweating (confirmed by interview). (4) Patients who are judged by the investigator, etc. to be inappropriate for this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Correlation coefficient between exercise loads in anaerobic thresthold and sweat lactate thresthold | — |
Secondary
| Measure | Time frame |
|---|---|
| (1) Correlation coefficient between exercise prescription using anaerobic thresthold and sweat lactate thresthold (2) Correlation coefficient between exercise loads in clinical anaerobic thresthold and sweat lactate thresthold (3) Reliability between evaluators of clinical anaerobic thresthold and sweat lactate thresthold | — |
Contacts
Public ContactYoshinori Katsumata
Keio University Hospital
Outcome results
None listed